Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 4, 2000, Pages

  Hayashi, Toshio ^b   Ito, Izumi ^a   Kano, Hatsuyo ^c   Endo, Hidetoshi ^a   Iguchi, Akihisa ^c  

^a CHUBU NATIONAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPROTEIN; CALCIUM CHLORIDE; CYCLIC GMP; DEOXYPYRIDINOLINE; ESTRIOL; ESTROGEN; GLYCERYL TRINITRATE; LIPID; NITRATE; NITRITE; OSTEOCALCIN; PROCOLLAGEN;

AGED; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; BONE DENSITY; BONE MINERAL; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HUMAN; LIPID BLOOD LEVEL; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0034015762     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.4.B183     Document Type: Article

References (40)

1. Stampfer JM, Colditz GA, Willeyy WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
2. Psaty BM, Heckbert SR, Atkins D, et al. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Arch Intern Med. 1993;153:1421-1427.
3. Walsh B, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein. N Engl J Med. 1991;325:1196-1204.
4. Perrot-Applanat M, Groyer-Picard MT, Garcia E, Lorenzo F, Miligrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology. 1988;123:1511-1519.
5. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996;94:727-733.
6. Gilligan DM, Badar DM, Panza JA, Quyyumi AA. Cannon RO III. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol. 1995;75:264-268.
7. Adams MR, Kaplan JF, Manuck SR, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis. 1990;10:1051-1057.
8. Suzuki A, Mizuno K, Ino Y, et al. Effect of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res. 1996;32: 516-523.
9. Keaney JF, Shwaery GT, Nicolosi RJ, Loscalzo J, Foxall T, Vita J. 17β-Estradiol preserves endothelial vasodilator function and limits low density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;92:2251-2259.
10. Adams MR, Clarkson TB, Kaplan JR, Kortnik DR. Ovarian secretions and atherosclerosis. In Naftolin F, Gutmann JN, DeCherney AH, eds. Ovarian Secretion and Cardiovascular and Neurological Function. New York: Raven; 1990:151-159.
11. Sullivan JM. Estrogen replacement. Circulation. 1996;94:2699-2702.
12. Jones G, Nguyen T, Kelly PJ, Eisman JA. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ. 1996;309:691-695.
13. Esposito G. Estriol: a weak estrogen or a different hormone? Gynecol Endocrinol. 1991;5:131-153.
14. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
15. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 1995;92:3431-3435.
16. Manual of Laboratory Operations. Lipid Research Clinics Program. Vol 1. Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health. DHEW Publication No. (NIH) 1974;75-628.
17. Seyedin SM, Kung VT, Daniloff YN, et al. Immunoassay for urinary pyridinoline. The new marker of bone resorption. J Bone Miner Res. 1993;8:635-641.
18. Yamada K, Nabeshima T. Simultaneous measurement of nitrite nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J Neurochem. 1997;68:1234-1243.
19. Chilvers ER, Giembycz MA, Challiss RA, Barnes BJ, Nahorski SR. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle. Br J Pharmacol. 1991;103:1119-1125.
20. Hayashi Y. Assessment of bone mass by image analysis of metacarpal bone roentgenograms: A quantitative digital image processing (DIP) method. Rad Med. 1990;8:173-178.
21. Goray I, Minaguchi H. Bone mass measurement in premenopausal, postmenopausal and senile women (Correlations between DIP method and DEXA values). Jpn Bone Assoc. 1991;1:135-140.
22. Lieberman EH, Gerhard MD, Uehataa A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
23. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol. 1995;114:955-960.
24. Hayashi T, Yamada K, Esaki T, Ishikawa T, Hidaka H, Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847-855.
25. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
26. Clarkson P, Celemajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997;96:3378-3383.
27. Blacke DM, Cummings SR, Genant HK, Nevitt MC, Palermo L, Browner WS. Axial bone density predicts fractures in older women. J Bone Miner Res. 1992;7:633-638.
28. Johnston CC, Hui SL, Witt RM, Applendorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab. 1985;61:905-911.
29. Parfitt AM, Mathews CHE, Villanueva AR, Kleereloper M, Frame B, Rao DS. Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest. 1983;289: 517-520.
30. Eastell R, Delmas PD, Hodgson SF, Erickson EF, Mann KG, Riggs BL. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers. J Clin Endocrinol Metabol. 1988;67:741-748.
31. Nguyen TV, Sambrook PN, Eisman JA. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss. J Bone Miner Res. 1997;12:124-135.
32. Lemon HM. Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine. Cancer Res. 1975;35: 1341-1353.
33. Bergink EW. Oestriol receptor interactions: their biological importance and therapeutic implications. Acta Endocrinol. 1980;233:9-16.
34. Vilska S, Punnonen R, Rauramo L. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides. Maturias. 1983;5:97-104.
35. Stohfeldt P. Clinical study on metabolic effects of estriol-succinate. Arzneimittel Forschung. 1977;27:2006-2008.
36. Toy JL, Davies JA, McNicol GP. The effects of long-term therapy with oestriol succinate on the haemostatic mechanism in postmenopausal women. Br J Obstet Gynecol. 1978;85:363-366.
37. Armour K, Ralston SH. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology. 1998;139:799-802.
38. Sasson S. Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol. 1991;39:59-69.
39. Delmis PD, Bjarnason NH, Mitlak BH, et al. Effects of Raloxifen on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med. 1997;337: 1614-1617.
40. Head KA. Estriol: safety and efficacy. Altern Med Rev. 1998;3:101-113.